Trial intelligence / Profile preview

EMI-137 for Intraoperative Imaging in Colon Cancer

NCT03360461Phase 2Completed

Sponsor
University of Leeds
Start
Feb 2018
Primary completion
Feb 2020
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of emi-137 in colon adenocarcinoma, sponsored by University of Leeds. Started Feb 2018; status: completed.

02

Drugs

emi-137
03

Conditions

colon adenocarcinoma

Beyond the preview

Go deeper on NCT03360461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03360461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call